Literature DB >> 16493065

Vaccine-induced memory CD8+ T cells cannot prevent central nervous system virus reactivation.

Chandran Ramakrishna1, Roscoe A Atkinson, Stephen A Stohlman, Cornelia C Bergmann.   

Abstract

Noncytopathic viruses use multiple strategies to evade immune detection, challenging a role for vaccine induced CTL in preventing microbial persistence. Recrudescence of neurotropic coronavirus due to loss of T cell-mediated immune control provided an experimental model to test T cell vaccination efficacy in the absence of Ab. Challenge virus was rapidly controlled in vaccinated Ab-deficient mice coincident with accelerated recruitment of memory CD8+ T cells and enhanced effector function compared with primary CD8+ T cell responses. In contrast to primary effectors, reactivated memory cells persisted in the CNS at higher frequencies and retained ex vivo cytolytic activity. Nevertheless, despite earlier and prolonged T cell-mediated control in the CNS of vaccinated mice, virus ultimately reactivated. Apparent loss of memory CD8+ effector function in vivo was supported by a prominent decline in MHC expression on CNS resident target cells, presumably reflecting diminished IFN-gamma. Severely reduced MHC expression on glial cells at the time of recrudescence suggested that memory T cells, although fully armed to exert antiviral activity upon Ag recognition in vitro, are not responsive in an environment presenting few if any target MHC molecules. Paradoxically, effective clearance of viral Ag thus affords persisting virus a window of opportunity to escape from immune surveillance. These studies demonstrate that vaccine-induced T cell memory alone is unable to control persisting virus in a tissue with strict IFN-dependent MHC regulation, as evident in immune privileged sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493065     DOI: 10.4049/jimmunol.176.5.3062

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus.

Authors:  Stephen A Stohlman; David R Hinton; Beatriz Parra; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

Review 2.  Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved.

Authors:  Carine Savarin; Cornelia C Bergmann
Journal:  Curr Opin Pharmacol       Date:  2008-06-16       Impact factor: 5.547

3.  Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.

Authors:  Timothy W Phares; Chandran Ramakrishna; Gabriel I Parra; Alan Epstein; Lieping Chen; Roscoe Atkinson; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

Review 4.  Pathogenesis of murine coronavirus in the central nervous system.

Authors:  Susan J Bender; Susan R Weiss
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-06       Impact factor: 4.147

5.  IL-15 independent maintenance of virus-specific CD8(+) T cells in the CNS during chronic infection.

Authors:  Jun Zuo; Stephen A Stohlman; Gabriel I Parra; Cornelia C Bergmann
Journal:  J Neuroimmunol       Date:  2008-12-23       Impact factor: 3.478

6.  Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis.

Authors:  Karen E Malone; Stephen A Stohlman; Chandran Ramakrishna; Wendy Macklin; Cornelia C Bergmann
Journal:  Glia       Date:  2008-03       Impact factor: 7.452

7.  Distinct regulation of MHC molecule expression on astrocytes and microglia during viral encephalomyelitis.

Authors:  Ludwig Hamo; Stephen A Stohlman; Maya Otto-Duessel; Cornelia C Bergmann
Journal:  Glia       Date:  2007-08-15       Impact factor: 7.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.